$9.11 Billion is the total value of FARALLON CAPITAL MANAGEMENT LLC's 72 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HLF | HERBALIFE LTD | $122,048,000 | +20.8% | 2,099,203 | 0.0% | 1.34% | +15.0% | |
| HERBALIFE LTDnote 2.000% 8/1 | $103,537,000 | +4.4% | 108,177,000 | 0.0% | 1.14% | -0.5% | ||
| SOLARCITY CORPnote 2.750%11/0 | $69,786,000 | +4.1% | 72,065,000 | 0.0% | 0.77% | -0.8% | ||
| TWX | TIME WARNER INCput | $55,695,000 | +1.2% | 570,000 | 0.0% | 0.61% | -3.6% | |
| SLD | SUTHERLAND ASSET MGMT CORP M | $33,585,000 | +7.4% | 2,324,236 | 0.0% | 0.37% | +2.2% | |
| H | HYATT HOTELS CORP | $33,144,000 | -2.3% | 614,000 | 0.0% | 0.36% | -6.9% | |
| GRFS | GRIFOLS S Asp adr rep b nvt | $20,383,000 | +17.5% | 1,079,874 | 0.0% | 0.22% | +12.0% | |
| CLUBQ | TOWN SPORTS INTL HLDGS INC | $14,413,000 | +42.0% | 4,060,082 | 0.0% | 0.16% | +35.0% | |
| NVET | NEXVET BIOPHARMA PUB LTD CO | $10,303,000 | +6.0% | 2,648,696 | 0.0% | 0.11% | +0.9% | |
| PCO | PENDRELL CORPcl a new | $5,337,000 | -3.7% | 821,061 | 0.0% | 0.06% | -7.8% | |
| GCVRZ | SANOFIright 12/31/2020 | $3,073,000 | +18.4% | 6,827,805 | 0.0% | 0.03% | +13.3% | |
| MITL | MITEL NETWORKS CORP | $2,677,000 | +1.9% | 386,267 | 0.0% | 0.03% | -3.3% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICROSOFT CORP | 41 | Q3 2023 | 3.7% |
| RADIUS HEALTH INC | 33 | Q2 2022 | 1.7% |
| GRIFOLS S A | 33 | Q4 2021 | 0.9% |
| ALPHABET INC | 32 | Q3 2023 | 4.2% |
| SPDR S&P 500 ETF TR | 31 | Q3 2023 | 25.3% |
| VISA INC | 30 | Q3 2023 | 2.9% |
| WABTEC CORP | 27 | Q3 2023 | 3.6% |
| EXELIXIS INC | 27 | Q3 2023 | 2.8% |
| ELEVANCE HEALTH INC | 26 | Q3 2023 | 2.6% |
| SAVARA INC | 26 | Q3 2023 | 0.3% |
View FARALLON CAPITAL MANAGEMENT LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Atento S.A. | March 15, 2023 | 2,230,357 | 15.4% |
| Metals Acquisition Corp | February 07, 2023 | 2,489,700 | 9.4% |
| Inflection Point Acquisition Corp. | February 06, 2023 | 1,900,000 | 5.8% |
| AMYRIS, INC. | February 24, 2022 | 1,068,904 | 0.3% |
| Swiftmerge Acquisition Corp. | February 14, 2022 | 291,060 | 1.3% |
| Caribou Biosciences, Inc. | February 11, 2022 | 2,428,150 | 4.0% |
| ENANTA PHARMACEUTICALS INC | February 11, 2022 | 287,000 | 1.4% |
| Protagonist Therapeutics, Inc | February 11, 2022 | 387,051 | 0.8% |
| Solid Power, Inc. | February 11, 2022 | ? | ? |
| Better Therapeutics, Inc. | February 09, 2022 | 124,065 | 0.5% |
View FARALLON CAPITAL MANAGEMENT LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR | 2024-02-14 |
| 13F-HR/A | 2024-02-12 |
| SC 13G/A | 2024-02-01 |
| SC 13G/A | 2024-01-23 |
View FARALLON CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.